Advanced Renal Cell Carcinoma

Evaluating Treatment-Free Survival in Patients With Advanced RCC
An analysis from Elaine Chang, MD, and colleagues evaluated treatment-free survival (TFS) in patients with advanced renal cell carcinoma (aRCC), both with and without continued toxicity, in trials of frontline immune-oncology (IO)–vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) combinations. Their research was published in Clinical Cancer Research. ...
Advertisement

Latest News

Advertisement

Knowledge Hub Spotlights

Curated clinical content based on conditions, therapies, and technologies

Renal Cell Carcinoma
Renal Cell Carcinoma

Conference Coverage

Advertisement
Section Editor

Advertisement
Get the latest RCC research straight to your inbox.